Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Ilias, I., Torpy, D. J., Pacak, K., Mullen, N., Wesley, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713
Self-citationBruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692 · cited 1×
“Pasireotide Pasireotide is a somatostatin receptor (SST) agonist that binds to four of the five SST subtypes with substantially higher affinity for SST1 and SST5 than octreotide or lanreotide (153, 154).”
BackgroundA 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Self-citationHall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Fleseriu, M., Biller, B. M. K., Findling, J. W., Molitch, M. E., Schteingart, D. E., Gross, C., on behalf of the SEISMIC Study Investigators, The SEISMIC Study Investigators include, Auchus, R., Bailey, T., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3350 · Cited by 479 · cited 2×
“Glucocorticoid receptor antagonist In one study, Mifepristone, a glucocorticoid receptor antagonist and antiprogestin, led to an improvement in hypertension and/or diabetes in 40 and 60%, respectively, of 34 patients (141).”
BackgroundSelf-citationColao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450
Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou, M. A., Mastorakos, G., Oldfield, E. H., Gomez, M. T., Doppman, J. L., Cutler, G. B., Nieman, L. K., & Chrousos, G. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311002 · Cited by 430 · cited 1×
“In two pediatric series using a strict criterion for remission (post-TSS serum cortisol of 1 g/dL [28 nmol/L] [41] or 1.”
MethodSelf-citationMultisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419 · cited 1×
“There is increased long-term risk of myocardial infarction (7, 8).”
BackgroundValassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0272 · Cited by 402 · cited 1×
“Quality of life Patients with active CS of any cause have impaired HRQOL compared to patients with other pituitary tumors (181, 193, 194).”
ResultSelf-citationARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Assié, G., Libé, R., Espiard, S., Rizk-Rabin, M., Guimier, A., Luscap, W., Barreau, O., Lefèvre, L., Sibony, M., Guignat, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304603 · Cited by 395
Hepatic Injury Associated With Ketoconazole Therapy
Lewis, J. H., Zimmerman, H. J., Benson, G. D., & Ishak, K. G. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80021-9 · Cited by 394
Estrada, J., Boronat, M., Mielgo, M., Magallón, R., Millán, I., Díez, S., Lucas, T., & Barceló, B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360303 · Cited by 383
Clayton, R. N., Raskauskiene, D., Reulen, R. C., & Jones, P. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1942 · Cited by 374
Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
Hammer, G. D., Tyrrell, J. B., Lamborn, K. R., Applebury, C. B., Hannegan, E. T., Bell, S., Rahl, R., Lu, A., & Wilson, C. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032180 · Cited by 374
Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358 · cited 2×
“However, these complications persist in many patients and should be addressed therapeutically before and after remission from CS (14, 15) (see below).”
BackgroundJoint IOF-ECTS GIO Guidelines Working Group, Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., Cooper, C., Diez Perez, A., Eastell, R., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1958-1 · Cited by 335
Pivonello, R., De Martino, M. C., Cappabianca, P., De Leo, M., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328
Takagi, K., & Usuku, G. (1969) · PubMed · Cited by 328
The significance of multiple, recurrent, and “complex” cardiac myxomas
McCarthy, P. M., Piehler, J. M., Schaff, H. V., Pluth, J. R., Orszulak, T. A., Vidaillet, H. J., & Carney, J. A. (1986) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36054-4 · Cited by 308
Verhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308 · cited 1×
“In the largest published single center series (91 patients), chronic therapy controlled hypercortisolemia in CD despite a rise in serum ACTH (127).”
BackgroundSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“scheme has been published elsewhere (2).”
Self-citationKetoconazole in Cushing's disease: is it worth a try?
Castinetti, F., Guignat, L., Giraud, P., Muller, M., Kamenicky, P., Drui, D., Caron, P., Luca, F., Donadille, B., Vantyghem, M. C., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3628 · Cited by 285 · cited 2×
“Mild asymptomatic elevation in serum transaminases occurs in approximately 10–15% of cases (121, 126), usually when therapy starts or when doses increase, so close monitoring is needed at these times.”
BackgroundResultSelf-citationHigh cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines
Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02168.x · Cited by 278 · cited 1×
“Fasting blood glucose may underdiagnose diabetes mellitus compared to an oral glucose tolerance test (178).”
BackgroundHofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
Atkinson, A. B., Kennedy, A., Wiggam, M. I., McCance, D. R., & Sheridan, B. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02380.x · Cited by 263
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Feelders, R. A., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., van Heerebeek, R., de Jong, F. H., van der Lely, A.-J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1000094 · Cited by 262
Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 2×
“Adults may experience persistent or new-onset atypical depressive disorders, anxiety, or panic symptoms (82).”
BackgroundFeelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia
Collins, M. T., Singer, F. R., & Eugster, E. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-s1-s4 · Cited by 256
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253
Radiation Therapy in the Management of Pituitary Adenomas
Loeffler, J. S., & Shih, H. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0251 · Cited by 239
Bourdeau, I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1949 · Cited by 239
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Self-citationAssié, G., Bahurel, H., Coste, J., Silvera, S., Kujas, M., Dugué, M.-A., Karray, F., Dousset, B., Bertherat, J., Legmann, P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1328 · Cited by 230
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Roelfsema, F., van Aken, M. O., Voormolen, J. H. C., & Romijn, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2112 · Cited by 223
Results of Treating Childhood Cushing's Disease with Pituitary Irradiation
Jennings, A. S., Liddle, G. W., & Orth, D. N. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711032971801 · Cited by 223
Kamenický, P., Droumaguet, C., Salenave, S., Blanchard, A., Jublanc, C., Gautier, J.-F., Brailly-Tabard, S., Leboulleux, S., Schlumberger, M., Baudin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0536 · Cited by 221
Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma
Miller, B. S., Ammori, J. B., Gauger, P. G., Broome, J. T., Hammer, G. D., & Doherty, G. M. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0532-2 · Cited by 221 · cited 1×
“Surgeons increasingly perform transperitoneal laparoscopic adrenalectomy, particularly for small tumors, but this is controversial because many recommend open surgery to assess stage and achieve en bloc resection (31, 32).”
BackgroundRepeat transsphenoidal surgery for Cushing's disease
Friedman, R. B., Oldfield, E. H., Nieman, L. K., Chrousos, G. P., Doppman, J. L., Cutler, G. B., & Loriaux, D. L. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.4.0520 · Cited by 211
Self-citationLindsay, J. R., Nansel, T., Baid, S., Gumowski, J., & Nieman, L. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1058 · Cited by 210 · cited 7×
“Quality of life Patients with active CS of any cause have impaired HRQOL compared to patients with other pituitary tumors (181, 193, 194).”
BackgroundInfluentialSelf-citationTreatment of Cushing's Disease by o,p′DDD: Survey of 62 Cases
Luton, J. P., Mahoudeau, J. A., Bouchard, P., Thieblot, P., Hautecouverture, M., Simon, D., Laudat, M. H., Touitou, Y., & Bricaire, H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903013000903 · Cited by 210
Tritos, N. A., Biller, B. M. K., & Swearingen, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.12 · Cited by 208
Self-citationIncidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study
Stuijver, D. J. F., van Zaane, B., Feelders, R. A., Debeij, J., Cannegieter, S. C., Hermus, A. R., van den Berg, G., Pereira, A. M., de Herder, W. W., Wagenmakers, M. A. E. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1661 · Cited by 208
Hofmann, B. M., Hlavac, M., Martinez, R., Buchfelder, M., Müller, O. A., & Fahlbusch, R. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/01/0009 · Cited by 206
Alexandraki, K. I., Kaltsas, G. A., Isidori, A. M., Storr, H. L., Afshar, F., Sabin, I., Akker, S. A., Chew, S. L., Drake, W. M., Monson, J. P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0921 · Cited by 203
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Godbout, A., Manavela, M., Danilowicz, K., Beauregard, H., Bruno, O. D., & Lacroix, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0382 · Cited by 202 · cited 4×
“Tumor volume decreased or remained stable in the small number of reported patients with visible adenomas (149, 150).”
BackgroundInfluentialKetoconazole treatment in Cushing’s syndrome: experience in 34 patients
Sonino, N., Boscaro, M., Paoletta, A., Mantero, F., & Zillotto, D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03547.x · Cited by 201
Park, H. S. (2009) · Archives of Surgery · doi:10.1001/archsurg.2009.191 · Cited by 201
Batista, D. L., Zhang, X., Gejman, R., Ansell, P. J., Zhou, Y., Johnson, S. A., Swearingen, B., Hedley-Whyte, E. T., Stratakis, C. A., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1245 · Cited by 201
Anticoagulant Prophylaxis Markedly Reduces Thromboembolic Complications in Cushing's Syndrome
Boscaro, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3662 · Cited by 198
Early repeat surgery for persistent Cushing's disease
Ram, Z., Nieman, L. K., Cutler, G. B., Chrousos, G. P., Doppman, J. L., & Oldfield, E. H. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.1.0037 · Cited by 194
Self-citationChiodini, I., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2387 · Cited by 191 · cited 1×
“However, retrospective studies suggest that patients with metabolic abnormalities are likely to benefit (29).”
BackgroundEfficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Baudry, C., Coste, J., Bou Khalil, R., Silvera, S., Guignat, L., Guibourdenche, J., Abbas, H., Legmann, P., Bertagna, X., & Bertherat, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0358 · Cited by 187 · cited 4×
“In three studies of patients with CD receiving mitotane for these indications, 72–82% had sustained hypercortisolism remission (107, 108, 110).”
BackgroundInfluentialPredictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients
Lambert, J. K., Goldberg, L., Fayngold, S., Kostadinov, J., Post, K. D., & Geer, E. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2893 · Cited by 186
Sarlis, N. J., Chanock, S. J., & Nieman, L. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6294 · Cited by 186
Self-citationMedical Therapy of Cushing's Disease
Nieman, L. K. (2002) · Pituitary · doi:10.1023/a:1022308429992 · Cited by 185
Self-citationPatronas, N., Bulakbasi, N., Stratakis, C. A., Lafferty, A., Oldfield, E. H., Doppman, J., & Nieman, L. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021438 · Cited by 185
Self-citationMortality and morbidity in Cushing's syndrome in New Zealand
Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04124.x · Cited by 182
Endocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181 · cited 1×
“Patients should be warned that this is common and expected (81).”
BackgroundEjaz, S., Vassilopoulou‐Sellin, R., Busaidy, N. L., Hu, M. I., Waguespack, S. G., Jimenez, C., Ying, A. K., Cabanillas, M., Abbara, M., & Habra, M. A. (2011) · Cancer · doi:10.1002/cncr.26029 · Cited by 180
Long‐term negative impact on quality of life in patients with successfully treated Cushing's disease
Heald, A. H., Ghosh, S., Bray, S., Gibson, C., Anderson, S. G., Buckler, H., & Fowler, H. L. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02118.x · Cited by 176
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing’s disease
Castinetti, F., Morange, I., Jaquet, P., Conte-Devolx, B., & Brue, T. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0514 · Cited by 175
Magiakou, M. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.1.131 · Cited by 173
On the various forms of corticosteroid withdrawal syndrome
Dixon, R. B., & Christy, N. P. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90358-7 · Cited by 172
Preda, V. A., Sen, J., Karavitaki, N., & Grossman, A. B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0274 · Cited by 172
Wind, J. J., Lonser, R. R., Nieman, L. K., DeVroom, H. L., Chang, R., & Oldfield, E. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3943 · Cited by 165
Self-citationHypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment
van der Pas, R., Leebeek, F. W. G., Hofland, L. J., de Herder, W. W., & Feelders, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12094 · Cited by 162
ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia
Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. D. P., Almeida, M. Q., Tremblay, J., Hamet, P., Bourdeau, I., Zerbini, M. C. N., Pereira, M. A. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4237 · Cited by 162
Cognitive decline in patients with Cushing's syndrome
FORGET, H., LACROIX, A., SOMMA, M., & COHEN, H. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700611037 · Cited by 161
Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease
Valassi, E., Biller, B. M. K., Swearingen, B., Pecori Giraldi, F., Losa, M., Mortini, P., Hayden, D., Cavagnini, F., & Klibanski, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1672 · Cited by 160
Self-citationSubtle cognitive impairments in patients with long-term cure of Cushing’s disease
Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2032 · Cited by 159 · cited 2×
“Deficits also occur in attention, visuospatial abilities, and working memory (185).”
BackgroundResultPrognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
Berruti, A., Fassnacht, M., Haak, H., Else, T., Baudin, E., Sperone, P., Kroiss, M., Kerkhofs, T., Williams, A. R., Ardito, A., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.11.006 · Cited by 158
SCHULTE, H. M., BENKER, G., REINWEIN, D., SIPPELL, W. G., & ALLOLIO, B. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1426 · Cited by 156
Petersenn, S., Beckers, A., Ferone, D., van der Lely, A., Bollerslev, J., Boscaro, M., Brue, T., Bruzzi, P., Casanueva, F. F., Chanson, P., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0883 · Cited by 156
Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2851 · Cited by 154
Vilar, L., Naves, L. A., Azevedo, M. F., Arruda, M. J., Arahata, C. M., Silva, L. M. E., Agra, R., Pontes, L., Montenegro, L., Albuquerque, J. L., et al. (2009) · Pituitary · doi:10.1007/s11102-009-0209-8 · Cited by 154
Outcome of Surgical Treatment of 200 Children With Cushing's Disease
Lonser, R. R., Wind, J. J., Nieman, L. K., Weil, R. J., DeVroom, H. L., & Oldfield, E. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3604 · Cited by 154
Self-citationOutcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years
Hassan-Smith, Z. K., Sherlock, M., Reulen, R. C., Arlt, W., Ayuk, J., Toogood, A. A., Cooper, M. S., Johnson, A. P., & Stewart, P. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2957 · Cited by 153
Use of Ketoconazole in the Treatment of Cushing’s Syndrome
LOLI, P., BERSELLI, M. E., & TAGLIAFERRI, M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1365 · Cited by 153
Pivonello, R., Matrone, C., Filippella, M., Cavallo, L. M., Somma, C. D., Cappabianca, P., Colao, A., Annunziato, L., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030859 · Cited by 152
Tauchmanovà, L., Pivonello, R., Di Somma, C., Rossi, R., De Martino, M. C., Camera, L., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0582 · Cited by 151
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
Lacroix, A., Bourdeau, I., Lampron, A., Mazzuco, T. L., Tremblay, J., & Hamet, P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03689.x · Cited by 150
Kroiss, M., Quinkler, M., Lutz, W. K., Allolio, B., & Fassnacht, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04214.x · Cited by 148
Biology, clinical characteristics, and management of adrenocortical tumors in children
Rodriguez‐Galindo, C., Figueiredo, B. C., Zambetti, G. P., & Ribeiro, R. C. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20318 · Cited by 146 · cited 1×
“In children, complete resection was associated with survival rates of 80%, whereas the outlook for unresectable disease was very poor (30).”
BackgroundNeuropsychiatric Disorders in Cushing’s Syndrome
Pereira, A. M., Tiemensma, J., & Romijn, J. A. (2010) · Neuroendocrinology · doi:10.1159/000314317 · Cited by 145
Cushing Syndrome in the McCune-Albright Syndrome
Brown, R. J., Kelly, M. H., & Collins, M. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2321 · Cited by 143
Increased risk of osteoporotic fractures in patients with Cushing's syndrome
Vestergaard, P., Lindholm, J., Jorgensen, J., Hagen, C., Hoeck, H., Laurberg, P., Rejnmark, L., Brixen, K., Kristensen, L., Feldt-Rasmussen, U., et al. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460051 · Cited by 138
Transsphenoidal Surgery for Pituitary Adenomas in Children
Dyer, E. H., Civit, T., Visot, A., Delalande, O., & Derome, P. (1994) · Neurosurgery · doi:10.1227/00006123-199402000-00001 · Cited by 137
Nelson, A. A., & Woodard, G. E. (1949) · PubMed · Cited by 135
Prevedello, D. M., Pouratian, N., Sherman, J., Jane, J. A., Vance, M. L., Lopes, M. B., & Laws, E. R. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/109/10/0751 · Cited by 135
Resmini, E., Santos, A., Gómez-Anson, B., Vives, Y., Pires, P., Crespo, I., Portella, M. J., de Juan-Delago, M., Barahona, M.-J., & Webb, S. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2231 · Cited by 133
Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation
SCHTEINGART, D. E., TSAO, H. S., TAYLOR, C. I., MCKENZIE, A., VICTORIA, R., & THERRIEN, B. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-5-613 · Cited by 131
AVGERINOS, P. C., CHROUSOS, G. P., NIEMAN, L. K., OLDFIELD, E. H., LORIAUX, D. L., & CUTLER, G. B. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-906 · Cited by 130
Self-citationvan der Pas, R., de Bruin, C., Leebeek, F. W. G., de Maat, M. P. M., Rijken, D. C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2753 · Cited by 124
Di Somma, C., Pivonello, R., Loche, S., Faggiano, A., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01713.x · Cited by 124
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
de Bruin, C., Pereira, A. M., Feelders, R. A., Romijn, J. A., Roelfsema, F., Sprij-Mooij, D. M., van Aken, M. O., van der Lelij, A.-J., de Herder, W. W., Lamberts, S. W. J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2101 · Cited by 124
Giordano, R., Picu, A., Marinazzo, E., D’Angelo, V., Berardelli, R., Karamouzis, I., Forno, D., Zinnà, D., Maccario, M., Ghigo, E., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04055.x · Cited by 122
Psychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. A. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 122
The survival and well‐being of patients treated for Cushing’s syndrome
Pikkarainen, L., Sane, T., & Reunanen, A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00483.x · Cited by 120
Final stature in patients with endogenous Cushing's syndrome
Magiakou, M. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1082 · Cited by 119
Grossman, A., Johannsson, G., Quinkler, M., & Zelissen, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0450 · Cited by 119
Metabolic Syndrome in Cushing’s Syndrome
Chanson, P., & Salenave, S. (2010) · Neuroendocrinology · doi:10.1159/000314272 · Cited by 118
Kristo, C., Jemtland, R., Ueland, T., Godang, K., & Bollerslev, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02067 · Cited by 118
Thompson, S. K., Hayman, A. V., Ludlam, W. H., Deveney, C. W., Loriaux, D. L., & Sheppard, B. C. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251578.03883.2f · Cited by 117
Elbelt, U., Trovato, A., Kloth, M., Gentz, E., Finke, R., Spranger, J., Galas, D., Weber, S., Wolf, C., König, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2648 · Cited by 115
Prolonged Treatment of Cushing's Disease by Ketoconazole
SONINO, N., BOSCARO, M., & MANTERO, F. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-4-718 · Cited by 114
Drake, W. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3542 · Cited by 113
Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole
Corcuff, J.-B., Young, J., Masquefa-Giraud, P., Chanson, P., Baudin, E., & Tabarin, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0913 · Cited by 113
Self-citationGeer, E. B., Shen, W., Strohmayer, E., Post, K. D., & Freda, P. U. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3123 · Cited by 112
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
Monaghan, P. J., Owen, L. J., Trainer, P. J., Brabant, G., Keevil, B. G., & Darby, D. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011014 · Cited by 111
Storr, H. L., Alexandraki, K. I., Martin, L., Isidori, A. M., Kaltsas, G. A., Monson, J. P., Besser, G. M., Matson, M., Evanson, J., Afshar, F., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1120 · Cited by 110
Self-citationAranda, G. B., Enseñat, J., Mora, M., Puig‐Domingo, M., de Osaba, M. J. M., Casals, G., Verger, E., Ribalta, T., Hanzu, F. A., & Halperín, I. (2014) · Pituitary · doi:10.1007/s11102-014-0567-8 · Cited by 109
Pituitary-Adrenal Response to the Antiglucocorticoid Action of RU 486 in Cushing's Syndrome*
BERTAGNA, X., BERTAGNA, C., LAUDAT, M.-H., HUSSON, J.-M., GIRARD, F., & LUTON, J.-P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-639 · Cited by 108
Wagenmakers, M. A. E. M., Netea-Maier, R. T., Prins, J. B., Dekkers, T., den Heijer, M., & Hermus, A. R. M. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0308 · Cited by 101
Salenave, S., Gatta, B., Pecheur, S., San-Galli, F., Visot, A., Lasjaunias, P., Roger, P., Berge, J., Young, J., Tabarin, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031908 · Cited by 101
Self-citationSomatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome
de Bruin, C., Feelders, R. A., Lamberts, S. W. J., & Hofland, L. J. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9082-4 · Cited by 100
Close, C. F., Mann, M. C., Watts, J. F., & Taylor, K. G. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02380.x · Cited by 99
Storr, H. L., Plowman, P. N., Carroll, P. V., François, I., Krassas, G. E., Afshar, F., Besser, G. M., Grossman, A. B., & Savage, M. O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021032 · Cited by 98
Self-citationFavorable long-term outcomes of bilateral adrenalectomy in Cushing's disease
Oßwald, A., Plomer, E., Dimopoulou, C., Milian, M., Blaser, R., Ritzel, K., Mickisch, A., Knerr, F., Stanojevic, M., Hallfeldt, K., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0214 · Cited by 93
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
Valassi, E., Crespo, I., Gich, I., Rodríguez, J., & Webb, S. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04424.x · Cited by 91
Cabergoline plus Lanreotide for Ectopic Cushing's Syndrome
Pivonello, R., Ferone, D., Lamberts, S. W. J., & Colao, A. (2005) · New England Journal of Medicine · doi:10.1056/nejm200506093522322 · Cited by 91
Final adult height and body mass index after cure of paediatric Cushing's disease
Davies, J. H., Storr, H. L., Davies, K., Monson, J. P., Besser, G. M., Afshar, F., Plowman, P. N., Grossman, A. B., & Savage, M. O. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02244.x · Cited by 88
Self-citationIsolated hyponatremia after transsphenoidal pituitary surgery
Olson, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.85 · Cited by 87
Bilateral Adrenalectomy for Refractory Cushing Disease: A Safe and Definitive Therapy
Smith, P. W., Turza, K. C., Carter, C. O., Vance, M. L., Laws, E. R., & Hanks, J. B. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.02.054 · Cited by 87
Tiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0307 · Cited by 87
de Bruin, C., Feelders, R. A., Waaijers, A. M., van Koetsveld, P. M., Sprij-Mooij, D. M., Lamberts, S. W. J., & Hofland, L. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0110 · Cited by 86
Fleseriu, M., Findling, J. W., Koch, C. A., Schlaffer, S.-M., Buchfelder, M., & Gross, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1843 · Cited by 86
Self-citationZancanella, P., Pianovski, M. A. D., de Oliveira, B. H., Ferman, S., Custódio, G., Lichtvan, L. C. L., Voss, S. Z., Stinghen, S. T., Caleffe, L. G., Parise, G. A., et al. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000212965.52759.1c · Cited by 85
Cushing’s Syndrome in Children and Adolescents
Mastorakos, G. P., & Kanaka‐Gantenbein, C. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_9 · Cited by 84
Feldt-Rasmussen, U., Abs, R., Bengtsson, B., Bennmarker, H., Bramnert, M., Hernberg-Stahl, E., Monson, J., Westberg, B., Wilton, P., & Wuster, C. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460067 · Cited by 84
Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome
Tabarin, A., Navarranne, A., Guérin, J., Corcuff, J. ‐., Parneix, M., & Roger, P. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01737.x · Cited by 83
Self-citationGreening, J. E., Brain, C. E., Perry, L. A., Mushtaq, I., Sales Marques, J., Grossman, A. B., & Savage, M. O. (2005) · Hormone Research in Paediatrics · doi:10.1159/000088587 · Cited by 82
Self-citationGlucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome
Tóth, M., & Grossman, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12189 · Cited by 81 · cited 2×
“It is not clear whether complete normalization occurs because the expected BMD for a given person cannot be predicted (8, 173, 200).”
BackgroundLiver injury associated with ketoconazole: Review of the published evidence
Greenblatt, H. K., & Greenblatt, D. J. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.400 · Cited by 81
Operative management of Cushing Syndrome secondary to micronodular adrenal hyperplasia
Powell, A. C., Stratakis, C. A., Patronas, N. J., Steinberg, S. M., Batista, D. L., Alexander, H. R., Pingpank, J. F., Keil, M. F., Bartlett, D. L., & Libutti, S. K. (2008) · Surgery · doi:10.1016/j.surg.2008.03.022 · Cited by 79
CLINICAL EXPERIENCE WITH KETOCONAZOLE AS A THERAPY FOR PATIENTS WITH CUSHING'S SYNDROME
MCCANCE, D. R., HADDEN, D. R., KENNEDY, L., SHERIDAN, B., & ATKINSON, A. B. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01189.x · Cited by 78
Yamada, S., Fukuhara, N., Nishioka, H., Takeshita, A., Inoshita, N., Itô, J., & Takeuchi, Y. (2011) · World Neurosurgery · doi:10.1016/j.wneu.2011.06.033 · Cited by 74
Liu, C., Lo, J. C., Dowd, C. F., Wilson, C. B., Kunwar, S., Aron, D. C., & Tyrrell, J. B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02115.x · Cited by 73
Ben-Shlomo, A., Schmid, H., Wawrowsky, K., Pichurin, O., Hubina, E., Chesnokova, V., Liu, N.-A., Culler, M., & Melmed, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1311 · Cited by 73
Minimally invasive adrenalectomy in children
Héloury, Y., Muthucumaru, M., Panabokke, G., Cheng, W., Kimber, C., & Leclair, M. (2012) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.08.003 · Cited by 72
Tiemensma, J., Biermasz, N. R., van der Mast, R. C., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1253 · Cited by 72
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing’s disease
Storr, H. L., Afshar, F., Matson, M., Sabin, I., Davies, K. M., Evanson, J., Plowman, P. N., Besser, G. M., Monson, J. P., Grossman, A. B., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01921 · Cited by 72
Self-citationHeredity and Cortisol Regulation in Bilateral Macronodular Adrenal Hyperplasia
Lacroix, A. (2013) · New England Journal of Medicine · doi:10.1056/nejme1312792 · Cited by 71
Swearingen, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3237 · Cited by 71
Xu, Y., Rui, W., Qi, Y., Zhang, C., Zhao, J., Wang, X., Wu, Y., Zhu, Q., Shen, Z., Ning, G., et al. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2059-9 · Cited by 71
Treatment of Cushing's Disease in Childhood and Adolescence by Stereotactic Pituitary Irradiation
Thoren, M., Rähn, T., Hallengren, B., Kaad, P.-H., NILSSON, K. O., RAVN, H., Ritzen, M. E., Petersen, K., & Aarskog, D. (1986) · Acta Paediatrica · doi:10.1111/j.1651-2227.1986.tb10219.x · Cited by 71
Dopamine Receptor Expression and Function in Corticotroph Ectopic Tumors
Pivonello, R., Ferone, D., de Herder, W. W., Faggiano, A., Bodei, L., de Krijger, R. R., Lombardi, G., Colao, A., Lamberts, S. W. J., & Hofland, L. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0728 · Cited by 68
Leong, G. M., Abad, V., Charmandari, E., Reynolds, J. C., Hill, S., Chrousos, G. P., & Nieman, L. K. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061010 · Cited by 68
Self-citationFütő, L., Tőke, J., Patócs, A., Szappanos, Á., Varga, I., Gláz, E., Tulassay, Z., Rácz, K., & Tóth, M. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0514-x · Cited by 67 · cited 1×
“The scant fracture data suggest that the increased symptomatic fracture risk disappears after curing CS, similar to that seen in exogenous glucocorticoid-induced osteoporosis (204, 206).”
BackgroundFleseriu, M., Molitch, M. E., Gross, C., SCHTEINGART, D. E., Vaughan, T. B., & Biller, B. M. K. (2013) · Endocrine Practice · doi:10.4158/ep12149.ra · Cited by 66
Self-citationPostoperative Testing to Predict Recurrent Cushing Disease in Children
Batista, D. L., Oldfield, E. H., Keil, M. F., & Stratakis, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0302 · Cited by 66
da Mota, F., Murray, C., & Ezzat, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1317 · Cited by 65
Webb, S. M., Mo, D., Lamberts, S. W. J., Melmed, S., Cavagnini, F., Pecori Giraldi, F., Strasburger, C. J., Zimmermann, A. G., Woodmansee, W. W., & on behalf of the International HypoCCS Advisory Board (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0806 · Cited by 64
Waiting for change: Symptom resolution after adrenalectomy for Cushing's syndrome
Sippel, R. S., Elaraj, D. M., Kebebew, E., Lindsay, S., Tyrrell, J., & Duh, Q. (2008) · Surgery · doi:10.1016/j.surg.2008.08.024 · Cited by 64
Lodish, M., Dunn, S. V., Sinaii, N., Keil, M. F., & Stratakis, C. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2325 · Cited by 63
Barahona, M.-J., Sucunza, N., Resmini, E., Fernández-Real, J.-M., Ricart, W., Moreno-Navarrete, J.-M., Puig, T., Wägner, A. M., Rodriguez-Espinosa, J., Farrerons, J., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090505 · Cited by 61
Blanco, C., Maqueda, E., Rubio, J. A., & Rodríguez, Á. A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344091 · Cited by 61
Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma
Baudry, C., Paepegaey, A. C., & Groussin, L. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1301428 · Cited by 61
Bou Khalil, R., Baudry, C., Guignat, L., Carrasco, C., Guibourdenche, J., Gaillard, S., Bertagna, X., & Bertherat, J. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0424 · Cited by 58
Aucott, J. N. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30091-4 · Cited by 56
Nella, A. A., Lodish, M. B., Fox, E., Balis, F. M., Quezado, M., Whitcomb, P. O., Derdak, J., Kebebew, E., Widemann, B. C., & Stratakis, C. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4340 · Cited by 52
Starke, R. M., Williams, B. J., Vance, M. L., & Sheehan, J. P. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833ab069 · Cited by 52
Castinetti, F., Martinie, M., Morange, I., Dufour, H., Sturm, N., Passagia, J.-G., Conte-Devolx, B., Chabre, O., & Brue, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2234 · Cited by 51
Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy.
Zeiger, M. A., Fraker, D. L., Pass, H. I., Nieman, L. K., Cutler, G. B., Chrousos, G. P., & Norton, J. A. (1993) · PubMed · Cited by 50
Self-citationStorr, H. L., Mitchell, H., Swords, F. M., Main, K. M., Hindmarsh, P. C., Betts, P. R., Shaw, N. J., Johnston, D. I., Clark, A. J. L., Reznek, R. H., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02124.x · Cited by 50
Self-citationEffect of surgical treatment on hypertension in Cushing's syndrome
Fallo, F. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00299-5 · Cited by 49
Loss of Body Cell Mass in Cushing's Syndrome: Effect of Treatment
Pirlich, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1078 · Cited by 49
Wilson, P. J., Williams, J. R., & Smee, R. I. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.04.007 · Cited by 47
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 45
The Effect of Dexamethasone on the Pharmacokinetics of Triazolam
Villikka, K., Kivistö, K. T., & Neuvonen, P. J. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01457.x · Cited by 45
Chan, L. F., Storr, H. L., Plowman, P. N., Perry, L. A., BESSER, G. M., Grossman, A. B., & Savage, M. O. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0588 · Cited by 43
Self-citationCarroll, P. V., Monson, J. P., Grossman, A. B., Besser, G. M., Plowman, P. N., Afshar, F., & Savage, M. O. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01922.x · Cited by 40
Self-citationSomatostatin analogs in ectopic corticotropin production
von Werder, K., Müller, O. A., & Stalla, G. K. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90107-9 · Cited by 40
Trainer, P. J., Eastment, C., Grossman, A. B., Wheeler, M. J., Perry, L., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02391.x · Cited by 39
Danet‐Lamasou, M., Asselineau, J., Perez, P., Vivot, A., Nunes, M., Loiseau, H., San‐Galli, F., Cherifi‐Gatta, B., Corcuff, J., & Tabarin, A. (2015) · Clinical Endocrinology · doi:10.1111/cen.12534 · Cited by 39
Self-citationSurgical strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome.
Zeiger, M. A., Pass, H. I., Doppman, J. D., Nieman, L. K., Chrousos, G. P., Cutler, G. B., Jensen, R. T., & Norton, J. A. (1992) · PubMed · Cited by 39
Self-citationBarroso‐Sousa, R., Lerário, A. M., Evangelista, J., Papadia, C., Lourenço, D. M., Lin, C. S., Kulcsar, M. A. V., Fragoso, M. C. B. V., & Hoff, A. O. (2014) · Thyroid · doi:10.1089/thy.2013.0571 · Cited by 38
Chan, L. F., Vaidya, M., Westphal, B., Allgrove, J., Martin, L., Afshar, F., Hindmarsh, P. C., Savage, M. O., Grossman, A. B., & Storr, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324419 · Cited by 37
Self-citationImpact of Technique on Cushing Disease Outcome Using Strict Remission Criteria
Alahmadi, H., Cusimano, M. D., Woo, K., Mohammed, A. A., Goguen, J., Smyth, H. S., Macdonald, R. L., Müller, P. J., Horváth, É., & Kovács, K. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710001427x · Cited by 35
Treatment of severe psychosis due to ectopic Cushing’s syndrome
Bilgin, Y. M., van der Wiel, H. E., Fischer, H. R. A., & de Herder, W. W. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03350817 · Cited by 35
Radiotherapy in paediatric Cushing’s disease: efficacy and long term follow up of pituitary function
Acharya, S. V., Gopal, R. A., Goerge, J., Menon, P. S., Bandgar, T., & Shah, N. S. (2010) · Pituitary · doi:10.1007/s11102-010-0231-x · Cited by 35
Tzanela, M., Karavitaki, N., Stylianidou, C., Tsagarakis, S., & Thalassinos, N. C. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2004.01976.x · Cited by 35
Farwell, A. P., Devlin, J. T., & Stewart, J. A. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90312-9 · Cited by 34
Cushing’s Syndrome during Pregnancy: Curative Adrenalectomy at 31 Weeks Gestation
Shaw, J., Pearson, D. W. M., Krukowski, Z. H., Fisher, P., & Bevan, J. S. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00148-3 · Cited by 30
Alexandraki, K. I., Kaltsas, G. A., Le Roux, C. W., Fassnacht, M., Ajodha, S., Christ‐Crain, M., Akker, S. A., Drake, W. M., Edwards, R., Allolio, B., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03631.x · Cited by 29
Benecke, R., Keller, E., Vetter, B., & de Zeeuw, R. A. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315440 · Cited by 29
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationCarey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.